Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#54 / 54 Total
TSBX - Turnstone Biologics Corp - Stock Price Chart
CompanyTurnstone Biologics Corp
Market Cap63.14MEPS (ttm)-3.27
P/E-EPS this Y39.12%
Forward P/E-EPS next Y12.20%
PEG-EPS past 5Y-
P/S-EPS next 5Y17.90%
P/B0.79EPS Q/Q-
Dividend-Sales Q/Q-100.00%
Insider Own42.77%Inst Own35.54%
Insider Trans0.00%Inst Trans-
Short Float5.06%EarningsMay 13/a
Analyst Recom1.00Target Price16.00
Avg Volume170.84K52W Range1.62 - 13.20
Turnstone Biologics Corp. operates as a clinical stage biotechnology company. It engages in the business of developing and commercializing therapeutics. The company is focused on developing new medicines to treat and cure patients with solid tumors. Turnstone Biologics was founded in 2015 and is headquartered in La Jolla, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jerel DavisDirectorJul 25 '23Buy12.00225,0002,700,0002,726,322Jul 27 04:21 PM
Versant Ventures V, LLC10% OwnerJul 25 '23Buy12.00225,0002,700,0002,726,322Jul 27 04:23 PM
ORBIMED ADVISORS LLCDirectorJul 20 '23Buy12.00416,6664,999,9923,099,265Jul 24 04:38 PM
Gupta RishiDirectorJul 20 '23Buy12.00416,6664,999,9923,099,265Jul 24 04:40 PM